Medication info

Januarine 25 mg (Sitagliptin Hydrochloride Hydrate)

Prescription medicationTabletOralExpired
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›28.35mg / 1 tablet
Manufacturer / importer
Il Yang Pharmaceutical Co., Ltd.
Appearance
Pink, round, biconvex, film-coated tablet
Packaging
28 tablets (14 tablets/PTPX2), 30 tablets (10 tablets/PTPX3)
Approval status
Expired

MFDS item code 202004064 · Approved 2020.05.29

This product's status changed to Expired on 2025.05.29. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
For monotherapy or combination therapy, administer 100 mg once daily; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When used in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia induced by the sulfonylurea or insulin (see Precautions for Use, section 5. General Precautions). Patients with renal impairment Because dosage adjustment according to renal function is required, assessment of renal function is recommended before treatment with this medicine and periodically thereafter. 1. No dosage adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dosage adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.

Ingredients

Manufacturer
Il Yang Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Difficulty in blood sugar control for patients with type 2 diabetes
View approved original text

This medication is used in combination with diet and exercise to help control blood sugar in patients with type 2 diabetes. It may be initiated as monotherapy, but for patients who have not previously taken diabetes medication, it can be used in combination with metformin. Additionally, if blood sugar control is challenging with monotherapy using sulfonylureas, metformin, thiazolidinediones, or insulin, this medication can be added to enhance therapeutic effectiveness. If blood sugar control remains insufficient even after the combination of various medications, this medication is added for improvement. It is a medication that effectively helps manage blood sugar in type 2 diabetes through various therapeutic combinations.

How to take

Adult dose

For monotherapy or combination therapy, administer 100 mg once daily; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When used in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia induced by the sulfonylurea or insulin (see Precautions for Use, section 5. General Precautions). Patients with renal impairment Because dosage adjustment according to renal function is required, assessment of renal function is recommended before treatment with this medicine and periodically thereafter. 1. No dosage adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dosage adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.

Precautions

This medication may cause severe allergic reactions, so if symptoms such as skin rash, difficulty breathing, swelling of the face or lips occur within 3 months of the initial dose, use should be discontinued immediately, and a doctor should be consulted. As there have been reports of severe side effects causing inflammation of the pancreas, known as acute pancreatitis, if symptoms such as abdominal pain, nausea, or vomiting arise during treatment, immediate medical attention should be sought. Patients diagnosed with type 1 diabetes, diabetic ketoacidosis, or those who have a hypersensitivity to this medication or its components should not take this medication. Patients with reduced kidney function need to adjust the dosage of this medication, so renal function tests should be performed, and it should be taken as directed by a physician. During treatment, symptoms resembling a cold, headaches, indigestion, diarrhea, etc., may occur; if symptoms are severe, patients should inform their doctor. When taken with other hypoglycemic agents, especially insulin or sulfonylureas, there may be an increased risk of hypoglycemia, so blood sugar levels should be regularly monitored, and dosage adjustments should be discussed with a physician if necessary. While taking this medication, symptoms such as joint pain or the formation of blisters on the skin may occur. If these symptoms arise, notify a doctor immediately and discontinue use if necessary. Pregnant or lactating women are advised not to take this medication, and safety and efficacy have not been established for children and adolescents under 18 years of age. Elderly patients may have impaired kidney function, so assessment of kidney function before taking this medication is required, and regular monitoring is necessary. In case of overdose, measures should be taken to remove the drug from the gastrointestinal tract, clinical monitoring, including an electrocardiogram, should be conducted, and hemodialysis may be considered if necessary. This medication has relatively few drug interactions, but caution should be taken when using digoxin concurrently.

Side effects

  • Hypersensitivity reaction
  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • exfoliative skin disease
  • acute pancreatitis
  • hypoglycemia
  • upper respiratory infection
  • rhinitis
  • headache
Show 26 more
  • diarrhea
  • abdominal pain
  • nausea
  • constipation
  • vomiting
  • severe and disabling arthralgia
  • vesiculobullous pemphigoid
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • elevated liver enzymes
  • acute renal failure
  • pneumonia
  • diabetes complications
  • metabolic acidosis
  • falls
  • cardiac arrest
  • dyspepsia
  • dizziness
  • increased blood triglycerides
  • gastritis
  • severe hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air from entering, and it is safest to store it at room temperature between 1 and 30 degrees Celsius. Storing it this way helps maintain the efficacy of the medication and prevents deterioration.

Appearance and packaging

Appearance

Pink, round, biconvex, film-coated tablet

Package unit

28 tablets (14 tablets/PTPX2), 30 tablets (10 tablets/PTPX3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.